XORTX_Therapeutics_Inc.jpg
XORTX Announces Notice to Grant European Patent
April 06, 2021 07:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, April 06, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing therapeutics for...
XORTX_Therapeutics_Inc.jpg
XORTX to Present at “Zoom With LD MICRO”
March 16, 2021 07:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, March 16, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative...
XORTX_Therapeutics_Inc.jpg
XORTX to Present and Participate in the Sachs 14th Annual European Life Sciences CEO Forum 2021
March 09, 2021 07:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, March 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative...
XORTX_Therapeutics_Inc.jpg
XORTX Files New Provisional Patent to Treat and Protect Individuals Most at Risk to Severe Viral Infection
March 08, 2021 09:12 ET | XORTX Therapeutics Inc.
● Compositions and Methods for Enhancing Anti-viral Therapies ● CALGARY, Alberta, March 08, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a...
XORTX_Therapeutics_Inc.jpg
XORTX Confirms $1 Million in Warrant Exercise Proceeds
March 02, 2021 07:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, March 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative...
XORTX_Therapeutics_Inc.jpg
XORTX Participating in WuXI Healthcare Forum
March 01, 2021 07:00 ET | XORTX Therapeutics Inc.
● Advancing Partner and Investor Outreach Activities ● CALGARY, Alberta, March 01, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a...
XORTX_Therapeutics_Inc.jpg
XORTX to Present at BIO CEO and Investor Conference
February 17, 2021 07:00 ET | XORTX Therapeutics Inc.
● Strategies to Decrease Acute and Chronic Kidney Injury, Co-morbidity and Mortality ● CALGARY, Alberta, Feb. 17, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE:...
XORTX_Therapeutics_Inc.jpg
XORTX Closes Over Subscribed Private Placement
February 10, 2021 07:00 ET | XORTX Therapeutics Inc.
CALGARY, Alberta, Feb. 10, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative...
XORTX_Therapeutics_Inc.jpg
XORTX Announces Over Subscribed Private Placement
February 08, 2021 07:00 ET | XORTX Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 08, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the...
XORTX_Therapeutics_Inc.jpg
XORTX Announces Increase to Private Placement
January 28, 2021 07:00 ET | XORTX Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Jan. 28, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the...